课题基金 / 基金详情

项目摘要

项目成果

MICHAEL Allan HOLINSTAT的其他基金

相似基金

相关文献

中文摘要
翻译
密歇根临床与健康研究所(MICHR)认识到需要一种高度熟练、多样化的 能够进行有影响力的临床和转化性研究以改善健康的劳动力。自.以来 自MICHR成立以来,培养一支多样化的翻译队伍一直是一项一贯的优先事项。这 优先事项包括在博士前培训的头几年内聘用博士前实习生,并直接向他们提供 经验与特定的教学培训相结合。经过十年的发展,我们目前的TL1- 支持的培训计划包括短期部分(暑期沉浸计划)和长期培训 临床研究计划理学硕士(MSCR)。该提案请求支持 每年招收10名短期学员和10名长期学员(增加1名学员)。受训人员将包括 专业前博士生(例如,医学生)和专业后学位实习生的混合体。 其他目标包括: 1.为TL1学员提供更多参与社区研究的机会。 2.通过正式培训教师导师有关指导技能的使用,支持学员的职业发展 来自国家研究指导网络的课程。 3.扩大支持MSCR学员发展的网络。 4.为TL1学员提供更多实习/实习经验。 5.为所有TL1学员制定、示范和传播基于能力的评估,以 提高翻译研究技能的测量水平。 这五个关键目标将使MICHR TL1计划能够有效地培训下一代翻译人员 科学家。目标是,在项目完成后,这些受训人员将高度参与并有动力 继续从事临床和翻译研究,能胜任临床翻译所需的技能 研究,经验丰富的多学科或跨专业团队成员,由高技能和 让导师参与,并在他们成功参与基于社区的研究的能力方面存在细微差别。
英文摘要
The Michigan Institute for Clinical & Health Research (MICHR) recognizes the need for a highly skilled, diverse workforce that can conduct impactful clinical and translational research that improves health. Since the inception of MICHR, the development of a diverse translational workforce has been a consistent priority. This priority includes engaging pre-doctoral trainees within their first few years of training and providing direct experience partnered with specific didactic training. Developed over the course of a decade, our current TL1- supported training programs include a short-term component (Summer Immersion Program) and a long-term component (the Master of Science in Clinical Research Program [MSCR]). This proposal requests support for 10 short-term trainees and 10 long-term trainees (an increase of one trainee) each year. Trainees will comprise a mixture of pre-professional doctoral students (e.g., medical student) and post-professional degree trainees. Other goals include: 1. Providing more opportunities for TL1 trainees to participate in community based research. 2. Supporting trainee career development by formally educating faculty mentors on mentoring skills using the curricula from the National Research Mentoring Network. 3. Expanding the network supporting the development of MSCR trainees. 4. Providing more intern/externship experiences for TL1 trainees. 5. Developing, demonstrating, and disseminating competency-based assessments for all TL1 trainees to improve the measurement of translational research skills. These five key goals will allow the MICHR TL1 programs to effectively train the next generation of translational scientists. The goal is that, upon program completion, these trainees will be highly engaged and motivated to continue work in clinical and translational research, competent in the skills necessary for clinical-translational research, experienced members of multidisciplinary or interprofessional teams led by highly skilled and engaged mentors, and nuanced in their capability to successfully participate in community based research.
期刊论文(59)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.amjmed.2021.06.018
发表时间: 2021-12
期刊: The American journal of medicine
影响因子: --
作者: [Garfein J, Cholack G, Krallman R, Feldeisen D, Montgomery D, Kline-Rogers E, Eagle K, Rubenfire M, Bumpus S]
通讯作者: Bumpus S
A Rare Case Report of Neurological Condition: Moersch-Woltman Syndrome with Positive Anti-GAD Antibodies.
神经系统疾病罕见病例报告:抗 GAD 抗体呈阳性的 Moersch-Woltman 综合征。
DOI: --
发表时间: 2023
期刊: International journal of medical students
影响因子: --
作者: [Pitliya,Aakanksha]
通讯作者: Pitliya,Aakanksha
Visual Field Defect Patterns Associated With Lesions of the Retrochiasmal Visual Pathway.
与视交叉后视觉通路病变相关的视野缺陷模式。
DOI: 10.1097/wno.0000000000001601
发表时间: 2022
期刊: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
影响因子: --
作者: [Cho,Juno, Liao,Eric, Trobe,JonathanD]
通讯作者: Trobe,JonathanD
DOI: 10.1080/13816810.2020.1776337
发表时间: 2020-08
期刊: Ophthalmic genetics
影响因子: 1.2
作者: [Lacy GD, Abalem MF, Popova LT, Santos EP, Yu G, Rakine HY, Rosenthal JM, Ehrlich JR, Musch DC, Jayasundera KT]
通讯作者: Jayasundera KT
共 42 条
    2022 Midwest Platelet Conference
    Biomarkers for 12-lipoxygenase inhibition as a therapeutic intervention for heparin-induced thrombocytopenia and thrombosis (HIT/T)
    • 批准号:
      10427382
    • 项目类别:
    • 资助金额:
      $23.36万
    • 财政年份:
      2021
    • 负责人:
      MICHAEL Allan HOLINSTAT
    • 依托单位:
    Biomarkers for 12-lipoxygenase inhibition as a therapeutic intervention for heparin-induced thrombocytopenia and thrombosis (HIT/T)
    • 批准号:
      10177358
    • 项目类别:
    • 资助金额:
      $20.86万
    • 财政年份:
      2021
    • 负责人:
      MICHAEL Allan HOLINSTAT
    • 依托单位:
    12-HETrE regulation of blood coagulation, hemostasis, and thrombosis
    海外基金